Literature DB >> 25977303

Leaflet area as a determinant of tricuspid regurgitation severity in patients with pulmonary hypertension.

Jonathan Afilalo1, Julia Grapsa2, Petros Nihoyannopoulos2, Jonathan Beaudoin2, J Simon R Gibbs2, Richard N Channick2, David Langleben2, Lawrence G Rudski2, Lanqi Hua2, Mark D Handschumacher2, Michael H Picard2, Robert A Levine2.   

Abstract

BACKGROUND: Tricuspid regurgitation (TR) is a risk factor for mortality in pulmonary hypertension (PH). TR severity varies among patients with comparable degrees of PH and right ventricular remodeling. The contribution of leaflet adaptation to the pathophysiology of TR has yet to be examined. We hypothesized that tricuspid leaflet area (TLA) is increased in PH, and that the adequacy of this increase relative to right ventricular remodeling determines TR severity. METHODS AND
RESULTS: A prospective cohort of 255 patients with PH from pre and postcapillary pathogeneses was assembled from 2 centers. Patients underwent a 3-dimensional echocardiogram focused on the tricuspid apparatus. TLA was measured with the Omni 4D software package. Compared with normal controls, patients with PH had a 2-fold increase in right ventricular volumes, 62% increase in annular area, and 49% increase in TLA. Those with severe TR demonstrated inadequate increase in TLA relative to the closure area, such that the ratio of TLA:closure area <1.78 was highly predictive of severe TR (odds ratio, 68.7; 95% confidence interval, 16.2-292.7). The median vena contracta width was 8.5 mm in the group with small TLA and large closure area as opposed to 4.8 mm in the group with large TLA and large closure area.
CONCLUSIONS: TLA plays a significant role in determining which patients with PH develop severe functional TR. The ratio of TLA:closure area, reflecting the balance between leaflet adaptation versus annular dilation and tethering forces, is an indicator of TR severity that may identify which patients stand to benefit from leaflet augmentation during tricuspid valve repair.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  echocardiography; pulmonary hypertension; tricuspid regurgitation

Mesh:

Year:  2015        PMID: 25977303      PMCID: PMC4435735          DOI: 10.1161/CIRCIMAGING.114.002714

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  36 in total

1.  Tricuspid leaflet augmentation to eliminate residual regurgitation in severe functional tricuspid regurgitation.

Authors:  Jong Bum Choi; Nan Yeol Kim; Kyung Hwa Kim; Min Ho Kim; Jung Ku Jo
Journal:  Ann Thorac Surg       Date:  2011-12       Impact factor: 4.330

2.  Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography.

Authors:  Lawrence G Rudski; Wyman W Lai; Jonathan Afilalo; Lanqi Hua; Mark D Handschumacher; Krishnaswamy Chandrasekaran; Scott D Solomon; Eric K Louie; Nelson B Schiller
Journal:  J Am Soc Echocardiogr       Date:  2010-07       Impact factor: 5.251

3.  Pathophysiology of tricuspid regurgitation: quantitative Doppler echocardiographic assessment of respiratory dependence.

Authors:  Yan Topilsky; Christophe Tribouilloy; Hector I Michelena; Sorin Pislaru; Douglas W Mahoney; Maurice Enriquez-Sarano
Journal:  Circulation       Date:  2010-09-27       Impact factor: 29.690

Review 4.  Evaluation of the tricuspid valve morphology and function by transthoracic real-time three-dimensional echocardiography.

Authors:  Luigi P Badano; Eustachio Agricola; Leopoldo Perez de Isla; Pasquale Gianfagna; Jose Louis Zamorano
Journal:  Eur J Echocardiogr       Date:  2009-06

5.  Echocardiographic approach to the decision-making process for tricuspid valve repair.

Authors:  Farideh Roshanali; Bahare Saidi; Mohammad Hossein Mandegar; Mohammad Ali Yousefnia; Farshid Alaeddini
Journal:  J Thorac Cardiovasc Surg       Date:  2009-11-11       Impact factor: 5.209

6.  The vena contracta in functional tricuspid regurgitation: a real-time three-dimensional color Doppler echocardiography study.

Authors:  Jong-Min Song; Min-Kyoung Jang; Yoon-Sil Choi; Yun-Jeong Kim; Sun-Yang Min; Dae-Hee Kim; Duk-Hyun Kang; Jae-Kwan Song
Journal:  J Am Soc Echocardiogr       Date:  2011-02-16       Impact factor: 5.251

7.  In vitro characterization of the mechanisms responsible for functional tricuspid regurgitation.

Authors:  Erin M Spinner; Patrick Shannon; Dana Buice; Jorge H Jimenez; Emir Veledar; Pedro J Del Nido; David H Adams; Ajit P Yoganathan
Journal:  Circulation       Date:  2011-08-01       Impact factor: 29.690

8.  Vena contracta width as a predictor of adverse outcomes in patients with severe isolated tricuspid regurgitation.

Authors:  Woo-In Yang; Chi-Young Shim; Min-Kyung Kang; Hyuk-Jae Chang; Namsik Chung; Seung-Yun Cho; Jong-Won Ha
Journal:  J Am Soc Echocardiogr       Date:  2011-08-05       Impact factor: 5.251

9.  Active adaptation of the tethered mitral valve: insights into a compensatory mechanism for functional mitral regurgitation.

Authors:  Jacob P Dal-Bianco; Elena Aikawa; Joyce Bischoff; J Luis Guerrero; Mark D Handschumacher; Suzanne Sullivan; Benjamin Johnson; James S Titus; Yoshiko Iwamoto; Jill Wylie-Sears; Robert A Levine; Alain Carpentier
Journal:  Circulation       Date:  2009-07-13       Impact factor: 29.690

10.  Functional tricuspid regurgitation in patients with pulmonary hypertension: is pulmonary artery pressure the only determinant of regurgitation severity?

Authors:  Diab Mutlak; Doron Aronson; Jonathan Lessick; Shimon A Reisner; Salim Dabbah; Yoram Agmon
Journal:  Chest       Date:  2008-08-21       Impact factor: 9.410

View more
  7 in total

Review 1.  Atrial Mitral and Tricuspid Regurgitation: Sex Matters. A Call for Action to Unravel the Differences Between Women and Men.

Authors:  Francisco Gual-Capllonch; José Ignacio Sáenz de Ibarra; Antoni Bayés-Genís; Victoria Delgado
Journal:  Front Cardiovasc Med       Date:  2022-06-13

2.  Independent predictors of developing pulmonary hypertension in heart failure with reduced versus preserved ejection fraction.

Authors:  Alaa Roushdy; Walaa Adel
Journal:  J Saudi Heart Assoc       Date:  2016-10-20

Review 3.  Pathophysiology and Diagnosis of Pulmonary Hypertension Due to Left Heart Disease.

Authors:  Athanasios Charalampopoulos; Robert Lewis; Peter Hickey; Charlotte Durrington; Charlie Elliot; Robin Condliffe; Ian Sabroe; David G Kiely
Journal:  Front Med (Lausanne)       Date:  2018-06-06

4.  Echocardiographic evaluation of the right ventricular dimension and systolic function in dogs with pulmonary hypertension.

Authors:  Tommaso Vezzosi; Oriol Domenech; Giulia Costa; Federica Marchesotti; Luigi Venco; Eric Zini; Maria Josefa Fernández Del Palacio; Rosalba Tognetti
Journal:  J Vet Intern Med       Date:  2018-09-14       Impact factor: 3.333

5.  The tricuspid valve also maladapts as shown in sheep with biventricular heart failure.

Authors:  William D Meador; Mrudang Mathur; Gabriella P Sugerman; Marcin Malinowski; Tomasz Jazwiec; Xinmei Wang; Carla Mr Lacerda; Tomasz A Timek; Manuel K Rausch
Journal:  Elife       Date:  2020-12-15       Impact factor: 8.140

6.  Reverse remodeling of tricuspid valve morphology and function in chronic thromboembolic pulmonary hypertension patients following pulmonary thromboendarterectomy: a cardiac magnetic resonance imaging and invasive hemodynamic study.

Authors:  Christian Alcaraz Frederiksen; Farhad Waziri; Steffen Ringgaard; Søren Mellemkjær; Tor Skibsted Clemmensen; Vibeke Elisabeth Hjortdal; Sten Lyager Nielsen; Steen Hvitfeldt Poulsen
Journal:  BMC Cardiovasc Disord       Date:  2021-09-17       Impact factor: 2.298

Review 7.  Atrial Functional Tricuspid Regurgitation as a Distinct Pathophysiological and Clinical Entity: No Idiopathic Tricuspid Regurgitation Anymore.

Authors:  Diana R Florescu; Denisa Muraru; Valentina Volpato; Mara Gavazzoni; Sergio Caravita; Michele Tomaselli; Pellegrino Ciampi; Cristina Florescu; Tudor A Bălșeanu; Gianfranco Parati; Luigi P Badano
Journal:  J Clin Med       Date:  2022-01-13       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.